Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Tango for Alzheimer's Disease Patients' Caregivers [NA]
Clinical trial update for a study titled 'Tango for Alzheimer's Disease Patients' Caregivers' sponsored by Emory University; the trial conce…
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Does EVOO Induce Gene and Metabolic Changes in Healthy Subjects [NA]
A clinical trial update from Augusta University investigates whether extra-virgin olive oil induces gene and metabolic changes in healthy su…
-
FDA approval · 2025-04-18FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for memantine hydrochloride (generic memantine) from Rising Pharma Holdings, Inc. This action confir…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia [Phase 1, Phase 2]
First-in-human evaluation of an EAAT2-targeted PET tracer for imaging dementia, currently in Phase 1/2 and recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Hearing Aid and Individuals With Cognitive Disorders [NA]
Completed clinical trial update on hearing aid use in individuals with cognitive disorders, including presbycusis, Alzheimer's disease (ApoE…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: At Home Gamma tACS in Alzheimer's Disease (tACS@Home) [NA]
A completed clinical trial evaluated at-home gamma tACS for Alzheimer's disease (tACS@Home). The provided snippet does not include trial res…
-
CLINICAL_TRIALS withdrawal · 2025-04-17Clinical Trial Update: A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age. [Phase 1]
A Phase 1 clinical trial investigating a novel therapeutic target for Alzheimer's disease in adults aged 50-85 was withdrawn.
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: An Open Platform of Serious Games for Cognitive Intervention [NA]
A University of Alberta-led clinical trial evaluating a platform of serious games for cognitive intervention in mild cognitive impairment an…
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Salsalate in Patients Mild to Moderate Alzheimer's Disease [Phase 1]
A Phase 1 trial evaluating Salsalate in patients with mild-to-moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP) [NA]
A clinical trial sponsored by the University of South Florida is evaluating palliative care education for dementia care providers in assiste…
-
EMA approval · 2025-04-15EMA Authorised: Prometax (rivastigmine) — Almirall, S.A.
The EMA authorised Prometax (rivastigmine) for the treatment of Alzheimer's disease, Parkinson's disease, and dementia. The decision date is…
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD [Phase 2]
A Phase 2 trial evaluating Bacillus Calmette-Guérin in adults with mild cognitive impairment and Alzheimer's disease has completed and poste…
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: Exploratory Evaluation of [11C]MPC6827 [EARLY_Phase 1]
An exploratory early Phase 1 study of the PET tracer [11C]MPC6827 conducted by Columbia University, reporting initial safety/imaging finding…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Safety and Target Engagement of Centella Asiatica in Cognitive Impairment [Phase 1]
Phase 1 clinical trial evaluating the safety and target engagement of Centella asiatica extract in individuals with mild cognitive impairmen…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease
This clinical trial update describes a study evaluating multimodal ophthalmic imaging and plasma biomarkers for early detection of Alzheimer…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Virtual Darkness Theraphy for Agitation in Dementia [NA]
A clinical trial update announcing the study of Virtual Darkness Therapy for agitation in dementia, including Alzheimer's disease, sponsored…
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: Partners at Meals - Respite Care and Home (PAM) [NA]
Clinical trial update for the PAM study (Partners at Meals - Respite Care and Home) sponsored by the Medical University of South Carolina; t…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Optical Neuroimaging and Cognition
The University of Cambridge is conducting a clinical trial on optical neuroimaging and cognition, currently recruiting participants with dem…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Clinical Safety and Efficacy of Fecal Microbiota Transplantation (FMT) in the Treatment of Alzheimer's Disease [NA]
This clinical trial update evaluates the safety and potential efficacy of fecal microbiota transplantation for Alzheimer's disease. The tria…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Music Therapy for Patients With Alzheimer's Disease [NA]
This clinical trial assesses the impact of music therapy in people with Mild Cognitive Impairment and Alzheimer's disease. The study is curr…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Clinical Study on Lymphaticovenous Anastomosis（LVA） for the Treatment of Alzheimer's Disease（AD） [NA]
This document notes a clinical study investigating lymphaticovenous anastomosis (LVA) as a treatment for Alzheimer's disease. Enrollment is …
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: SUPPORT-D Intervention for Persons With Alzheimer's Disease and Their Caregivers [NA]
The SUPPORT-D trial evaluating an intervention for persons with Alzheimer’s disease and their caregivers has completed, with results posted …
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-MAPTRx in Patients With Mild Alzheimer's Disease [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of IONIS-MAPTRx in patients with mild Alzheimer's dise…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Finding Retinal Biomarkers in Alzheimer's Disease
This completed clinical trial investigates retinal biomarkers in Alzheimer disease to evaluate eye-based indicators of the disease.
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Efficacy of HellenCare in Early-Stage Alzheimer's Disease [NA]
An update on the HellenCare trial reports efficacy signals in early-stage Alzheimer's disease. The study status is NOT_YET_RECRUITING.